PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 2220683

A knowledge-based system for transfusion advice.

K A Spackman·J R Beck
View original source ↗Export metadata ↓

Abstract

A knowledge-based system has been designed for evaluating the appropriateness of transfusion of non-red blood cell blood components. The goal of the system is to assist the blood bank physician in quality assurance efforts by automatically identifying cases of inappropriate transfusion before the blood is issued. Evaluation of a working prototype system shows that it is indeed capable of serving this function. The system identifies and summarizes cases, but it leaves consultation, education, and decision making to the blood bank physician. Small "expert systems" such as this may find use in quality assurance activities throughout the laboratory.

Explore related subjects

Blood TransfusionExpert SystemsQuality ControlJournal ArticleResearch Support, U.S. Gov't, P.H.S.Review

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K A Spackman, J R Beck. 1990. A knowledge-based system for transfusion advice.. https://pubmed.ncbi.nlm.nih.gov/2220683/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1992

Autologous blood transfusion in Auckland.

AIMS: To review autologous blood collection and transfusion practice in Auckland over the last five years. METHOD: Records of autologous blood collections were obtained from blood collection centre records and results of transfusions on patients from hospital notes. RESULTS: One hundred and sixty-four units of blood were collected from 77 patients. Seventy-five percent of the units collected were transfused. Most autologous blood was transfused to private hospital patients. Only 8% of patients required homologous blood. CONCLUSIONS: There has been a slow increase of autologous blood collection and transfusion in the Auckland area, as well as in the rest of New Zealand. The present risks of homologous transfusion, particularly since the introduction of hepatitis C testing, appear very low. A further expansion of the present autologous blood programme would entail increased expenditure and it is suggested that a critical cost benefit analysis would be useful before the programme is expanded.

Blood Transfusion↗